{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:53:18Z","timestamp":1784256798041,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T00:00:00Z","timestamp":1566000000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T00:00:00Z","timestamp":1566000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH107615"],"award-info":[{"award-number":["MH107615"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01BX004062"],"award-info":[{"award-number":["1I01BX004062"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00213-019-05347-4","type":"journal-article","created":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T21:42:51Z","timestamp":1566078171000},"page":"93-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Classical conditioning of antidepressant placebo effects in mice"],"prefix":"10.1007","volume":"237","author":[{"given":"Samuel R.","family":"Krimmel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panos","family":"Zanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polymnia","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Colloca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1511-7183","authenticated-orcid":false,"given":"Todd D.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,17]]},"reference":[{"key":"5347_CR1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.addbeh.2004.03.020","volume":"29","author":"K Abrams","year":"2004","unstructured":"Abrams K, Kushner MG (2004) The moderating effects of tension-reduction alcohol outcome expectancies on placebo responding in individuals with social phobia. Addict Behav 29:1221\u20131224","journal-title":"Addict Behav"},{"key":"5347_CR2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1037\/h0076384","volume":"43","author":"PJ Aletky","year":"1975","unstructured":"Aletky PJ, Carlin AS (1975) Sex differences and placebo effects: motivation as an intervening variable. J Consult Clin Psychol 43:278","journal-title":"J Consult Clin Psychol"},{"key":"5347_CR3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1523\/JNEUROSCI.19-01-00484.1999","volume":"19","author":"M Amanzio","year":"1999","unstructured":"Amanzio M, Benedetti F (1999) Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 19:484\u2013494","journal-title":"J Neurosci"},{"key":"5347_CR4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1192\/bjp.178.3.192","volume":"178","author":"G Andrews","year":"2001","unstructured":"Andrews G (2001) Placebo response in depression: bane of research, boon to therapy. Br J Psychiatry 178:192\u2013194","journal-title":"Br J Psychiatry"},{"key":"5347_CR5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/PSY.0b013e31818105ed","volume":"70","author":"PM Aslaksen","year":"2008","unstructured":"Aslaksen PM, Flaten MA (2008) The roles of physiological and subjective stress in the effectiveness of a placebo on experimentally induced pain. Psychosom Med 70:811\u2013818","journal-title":"Psychosom Med"},{"key":"5347_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/PSY.0b013e3182080d73","volume":"73","author":"PM Aslaksen","year":"2011","unstructured":"Aslaksen PM, Bystad M, Vambheim SM, Flaten MA (2011) Gender differences in placebo analgesia: event-related potentials and emotional modulation. Psychosom Med 73:193\u2013199","journal-title":"Psychosom Med"},{"key":"5347_CR7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, Kavalali ET, Monteggia LM (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475:91\u201395","journal-title":"Nature"},{"key":"5347_CR8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nn1250","volume":"7","author":"F Benedetti","year":"2004","unstructured":"Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, Pesare M, Bergamasco B, Lopiano L (2004) Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci 7:587\u2013588","journal-title":"Nat Neurosci"},{"key":"5347_CR9","doi-asserted-by":"crossref","first-page":"10390","DOI":"10.1523\/JNEUROSCI.3458-05.2005","volume":"25","author":"F Benedetti","year":"2005","unstructured":"Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK (2005) Neurobiological mechanisms of the placebo effect. J Neurosci 25:10390\u201310402","journal-title":"J Neurosci"},{"key":"5347_CR10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351\u2013354","journal-title":"Biol Psychiatry"},{"key":"5347_CR11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00213-011-2233-4","volume":"215","author":"E Bjorkedal","year":"2011","unstructured":"Bjorkedal E, Flaten MA (2011) Interaction between expectancies and drug effects: an experimental investigation of placebo analgesia with caffeine as an active placebo. Psychopharmacology 215:537\u2013548","journal-title":"Psychopharmacology"},{"key":"5347_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2012.12.009","volume":"70","author":"N Carrier","year":"2013","unstructured":"Carrier N, Kabbaj M (2013) Sex differences in the antidepressant-like effects of ketamine. Neuropharmacology 70:27\u201334","journal-title":"Neuropharmacology"},{"key":"5347_CR13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuroscience.2015.08.017","volume":"307","author":"B Colagiuri","year":"2015","unstructured":"Colagiuri B, Schenk LA, Kessler MD, Dorsey SG, Colloca L (2015) The placebo effect: from concepts to genes. Neuroscience 307:171\u2013190","journal-title":"Neuroscience"},{"key":"5347_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-pharmtox-010818-021542","volume":"59","author":"L Colloca","year":"2019","unstructured":"Colloca L (2019) The placebo effect in pain therapies. Annu Rev Pharmacol Toxicol 59:191\u2013211","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5347_CR15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.pain.2013.02.002","volume":"154","author":"L Colloca","year":"2013","unstructured":"Colloca L, Klinger R, Flor H, Bingel U (2013) Placebo analgesia: psychological and neurobiological mechanisms. Pain 154:511\u2013514","journal-title":"Pain"},{"key":"5347_CR16","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/j.pain.0000000000000566","volume":"157","author":"L Colloca","year":"2016","unstructured":"Colloca L, Enck P, DeGrazia D (2016a) Relieving pain using dose-extending placebos: a scoping review. Pain 157:1590\u20131598","journal-title":"Pain"},{"key":"5347_CR17","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.biopsych.2015.07.019","volume":"79","author":"L Colloca","year":"2016","unstructured":"Colloca L, Pine DS, Ernst M, Miller FG, Grillon C (2016b) Vasopressin boosts placebo analgesic effects in women: a randomized trial. Biol Psychiatry 79:794\u2013802","journal-title":"Biol Psychiatry"},{"key":"5347_CR18","doi-asserted-by":"publisher","unstructured":"Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, Sanacora G, Wilkinson ST, Papakostas GI (2018) Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Mol Psychiatry. \nhttps:\/\/doi.org\/10.1038\/s41380-018-0256-5\n\n. \nhttps:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30283029","DOI":"10.1038\/s41380-018-0256-5"},{"key":"5347_CR19","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1007\/s00213-014-3664-5","volume":"231","author":"G Fond","year":"2014","unstructured":"Fond G, Loundou A, Rabu C, Macgregor A, Lancon C, Brittner M, Micoulaud-Franchi JA, Richieri R, Courtet P, Abbar M, Roger M, Leboyer M, Boyer L (2014) Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology 231:3663\u20133676","journal-title":"Psychopharmacology"},{"key":"5347_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","volume":"303","author":"JC Fournier","year":"2010","unstructured":"Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J (2010) Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 303:47\u201353","journal-title":"JAMA"},{"key":"5347_CR21","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S2215-0366(16)30307-8","volume":"3","author":"TA Furukawa","year":"2016","unstructured":"Furukawa TA, Cipriani A, Atkinson LZ, Leucht S, Ogawa Y, Takeshima N, Hayasaka Y, Chaimani A, Salanti G (2016) Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies. Lancet Psychiatry 3:1059\u20131066","journal-title":"Lancet Psychiatry"},{"key":"5347_CR22","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1096\/fj.02-0389com","volume":"16","author":"MU Goebel","year":"2002","unstructured":"Goebel MU, Trebst AE, Steiner J, Xie YF, Exton MS, Frede S, Canbay AE, Michel MC, Heemann U, Schedlowski M (2002) Behavioral conditioning of immunosuppression is possible in humans. FASEB J 16:1869\u20131873","journal-title":"FASEB J"},{"key":"5347_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00401706.1969.10490657","volume":"11","author":"FE Grubbs","year":"1969","unstructured":"Grubbs FE (1969) Procedures for detecting outlying observations in samples. Technometrics 11:1\u201321","journal-title":"Technometrics"},{"key":"5347_CR24","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1177\/0269881109104848","volume":"24","author":"JY Guo","year":"2010","unstructured":"Guo JY, Wang JY, Luo F (2010) Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems. J Psychopharmacol 24:1561\u20131567","journal-title":"J Psychopharmacol"},{"key":"5347_CR25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00213-011-2259-7","volume":"217","author":"JY Guo","year":"2011","unstructured":"Guo JY, Yuan XY, Sui F, Zhang WC, Wang JY, Luo F, Luo J (2011) Placebo analgesia affects the behavioral despair tests and hormonal secretions in mice. Psychopharmacology 217:83\u201390","journal-title":"Psychopharmacology"},{"key":"5347_CR26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/bs.irn.2018.01.001","volume":"138","author":"M Hadamitzky","year":"2018","unstructured":"Hadamitzky M, Sondermann W, Benson S, Schedlowski M (2018) Placebo effects in the immune system. Int Rev Neurobiol 138:39\u201359","journal-title":"Int Rev Neurobiol"},{"key":"5347_CR27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/syn.20541","volume":"62","author":"LT Haltia","year":"2008","unstructured":"Haltia LT, Rinne JO, Helin S, Parkkola R, Nagren K, Kaasinen V (2008) Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function. Synapse 62:682\u2013688","journal-title":"Synapse"},{"key":"5347_CR28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1126\/science.138.3541.677","volume":"138","author":"RJ Herrnstein","year":"1962","unstructured":"Herrnstein RJ (1962) Placebo effect in the rat. Science 138:677\u2013678","journal-title":"Science"},{"key":"5347_CR29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuroimage.2016.12.032","volume":"147","author":"A Hoflich","year":"2017","unstructured":"Hoflich A, Ganger S, Tik M, Hahn A, Kranz GS, Vanicek T, Spies M, Kraus C, Windischberger C, Kasper S, Winkler D, Lanzenberger R (2017) Imaging the neuroplastic effects of ketamine with VBM and the necessity of placebo control. Neuroimage 147:198\u2013203","journal-title":"Neuroimage"},{"key":"5347_CR30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0091-3057(94)00379-W","volume":"51","author":"M Irifune","year":"1995","unstructured":"Irifune M, Shimizu T, Nomoto M, Fukuda T (1995) Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice. Pharmacol Biochem Behav 51:291\u2013296","journal-title":"Pharmacol Biochem Behav"},{"key":"5347_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2018.02.001","volume":"138","author":"A Keller","year":"2018","unstructured":"Keller A, Akintola T, Colloca L (2018) Placebo analgesia in rodents: current and future research. Int Rev Neurobiol 138:1\u201315","journal-title":"Int Rev Neurobiol"},{"key":"5347_CR32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/ebmh.13.2.49","volume":"13","author":"I Kirsch","year":"2010","unstructured":"Kirsch I (2010) Review: benefits of antidepressants over placebo limited except in very severe depression. Evid Based Ment Health 13:49","journal-title":"Evid Based Ment Health"},{"key":"5347_CR33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-3-662-44519-8_16","volume":"225","author":"I Kirsch","year":"2014","unstructured":"Kirsch I (2014) The emperor\u2019s new drugs: medication and placebo in the treatment of depression. Handb Exp Pharmacol 225:291\u2013303","journal-title":"Handb Exp Pharmacol"},{"key":"5347_CR34","doi-asserted-by":"crossref","unstructured":"Kirsch I, Sapirstein G (1998) Listening to Prozac but hearing placebo: a meta-analysis of antidepressant medication. Prev Treat 1:2a. \nhttps:\/\/psycnet.apa.org\/doiLanding?doi=10.1037%2F1522-3736.1.1.12a","DOI":"10.1037\/1522-3736.1.1.12a"},{"key":"5347_CR35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050045","volume":"5","author":"I Kirsch","year":"2008","unstructured":"Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5:e45","journal-title":"PLoS Med"},{"key":"5347_CR36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jpsychores.2008.09.019","volume":"66","author":"S Klosterhalfen","year":"2009","unstructured":"Klosterhalfen S, Kellermann S, Braun S, Kowalski A, Schrauth M, Zipfel S, Enck P (2009) Gender and the nocebo response following conditioning and expectancy. J Psychosom Res 66:323\u2013328","journal-title":"J Psychosom Res"},{"key":"5347_CR37","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jpain.2014.09.005","volume":"15","author":"P Krummenacher","year":"2014","unstructured":"Krummenacher P, Kossowsky J, Schwarz C, Brugger P, Kelley JM, Meyer A, Gaab J (2014) Expectancy-induced placebo analgesia in children and the role of magical thinking. J Pain 15:1282\u20131293","journal-title":"J Pain"},{"key":"5347_CR38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199\u2013214","journal-title":"Arch Gen Psychiatry"},{"key":"5347_CR39","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.biopsych.2014.03.026","volume":"76","author":"KA Lapidus","year":"2014","unstructured":"Lapidus KA, Levitch CF, Perez AM, Brallier JW, Parides MK, Soleimani L, Feder A, Iosifescu DV, Charney DS, Murrough JW (2014) A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry 76:970\u2013976","journal-title":"Biol Psychiatry"},{"key":"5347_CR40","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329:959\u2013964","journal-title":"Science"},{"key":"5347_CR41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","volume":"63","author":"S Maeng","year":"2008","unstructured":"Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G, Manji HK (2008) Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 63:349\u2013352","journal-title":"Biol Psychiatry"},{"key":"5347_CR42","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1176\/appi.ajp.159.5.728","volume":"159","author":"HS Mayberg","year":"2002","unstructured":"Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, Jerabek PA (2002) The functional neuroanatomy of the placebo effect. Am J Psychiatry 159:728\u2013737","journal-title":"Am J Psychiatry"},{"key":"5347_CR43","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.pain.2014.07.004","volume":"155","author":"CT McNabb","year":"2014","unstructured":"McNabb CT, White MM, Harris AL, Fuchs PN (2014) The elusive rat model of conditioned placebo analgesia. Pain 155:2022\u20132032","journal-title":"Pain"},{"key":"5347_CR44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1467-9280.1996.tb00352.x","volume":"7","author":"G Montgomery","year":"1996","unstructured":"Montgomery G, Kirsch I (1996) Mechanisms of placebo pain reduction: an empirical investigation. Psychol Sci 7:174\u2013176","journal-title":"Psychol Sci"},{"key":"5347_CR45","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","volume":"170","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ (2013) Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry 170:1134\u20131142","journal-title":"Am J Psychiatry"},{"key":"5347_CR46","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1353\/pbm.2018.0051","volume":"61","author":"N Peiris","year":"2018","unstructured":"Peiris N, Blasini M, Wright T, Colloca L (2018) The placebo phenomenon: a narrow focus on psychological models. Perspect Biol Med 61:388\u2013400","journal-title":"Perspect Biol Med"},{"key":"5347_CR47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","volume":"177","author":"B Petit-Demouliere","year":"2005","unstructured":"Petit-Demouliere B, Chenu F, Bourin M (2005) Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 177:245\u2013255","journal-title":"Psychopharmacology"},{"key":"5347_CR48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3959(01)00296-2","volume":"93","author":"A Pollo","year":"2001","unstructured":"Pollo A, Amanzio M, Arslanian A, Casadio C, Maggi G, Benedetti F (2001) Response expectancies in placebo analgesia and their clinical relevance. Pain 93:77\u201384","journal-title":"Pain"},{"key":"5347_CR49","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/mp.2017.36","volume":"22","author":"MJ Ramaker","year":"2017","unstructured":"Ramaker MJ, Dulawa SC (2017) Identifying fast-onset antidepressants using rodent models. Mol Psychiatry 22:656\u2013665","journal-title":"Mol Psychiatry"},{"key":"5347_CR50","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163:1905\u20131917","journal-title":"Am J Psychiatry"},{"key":"5347_CR51","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.biopsych.2015.12.025","volume":"80","author":"A Sarkar","year":"2016","unstructured":"Sarkar A, Kabbaj M (2016) Sex differences in effects of ketamine on behavior, spine density, and synaptic proteins in socially isolated rats. Biol Psychiatry 80:448\u2013456","journal-title":"Biol Psychiatry"},{"key":"5347_CR52","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","volume":"173","author":"JB Singh","year":"2016","unstructured":"Singh JB, Fedgchin M, Daly EJ, De Boer P, Cooper K, Lim P, Pinter C, Murrough JW, Sanacora G, Shelton RC, Kurian B, Winokur A, Fava M, Manji H, Drevets WC, Van Nueten L (2016) A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. Am J Psychiatry 173:816\u2013826","journal-title":"Am J Psychiatry"},{"key":"5347_CR53","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1017\/S1092852900023117","volume":"10","author":"DJ Stein","year":"2005","unstructured":"Stein DJ, Mayberg H (2005) Placebo: the best pill of all. CNS Spectr 10:440\u2013442","journal-title":"CNS Spectr"},{"key":"5347_CR54","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2147\/JPR.S134745","volume":"10","author":"SM Vambheim","year":"2017","unstructured":"Vambheim SM, Flaten MA (2017) A systematic review of sex differences in the placebo and the nocebo effect. J Pain Res 10:1831\u20131839","journal-title":"J Pain Res"},{"key":"5347_CR55","volume-title":"Zarate CA","author":"ST Wilkinson","year":"2019","unstructured":"Wilkinson ST, Farmer C, Ballard ED, Mathew SJ, Grunebaum MF, Murrough JW, Sos P, Wang G, Gueorguieva R (2019) Zarate CA. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant, Neuropsychopharmacology"},{"key":"5347_CR56","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","volume":"23","author":"P Zanos","year":"2018","unstructured":"Zanos P, Gould TD (2018) Mechanisms of ketamine action as an antidepressant. Mol Psychiatry 23:801\u2013811","journal-title":"Mol Psychiatry"},{"key":"5347_CR57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/jpet.115.225664","volume":"355","author":"P Zanos","year":"2015","unstructured":"Zanos P, Piantadosi SC, Wu HQ, Pribut HJ, Dell MJ, Can A, Snodgrass HR, Zarate CA Jr, Schwarcz R, Gould TD (2015) The prodrug 4-chlorokynurenine causes ketamine-like antidepressant effects, but not side effects, by NMDA\/glycineB-site inhibition. J Pharmacol Exp Ther 355:76\u201385","journal-title":"J Pharmacol Exp Ther"},{"key":"5347_CR58","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, Alkondon M, Yuan P, Pribut HJ, Singh NS, Dossou KS, Fang Y, Huang XP, Mayo CL, Wainer IW, Albuquerque EX, Thompson SM, Thomas CJ, Zarate CA Jr, Gould TD (2016) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533:481\u2013486","journal-title":"Nature"},{"key":"5347_CR59","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate Jr","year":"2006","unstructured":"Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856\u2013864","journal-title":"Arch Gen Psychiatry"},{"key":"5347_CR60","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1017\/S1461145712000673","volume":"16","author":"RR Zhang","year":"2013","unstructured":"Zhang RR, Zhang WC, Wang JY, Guo JY (2013) The opioid placebo analgesia is mediated exclusively through mu-opioid receptor in rat. Int J Neuropsychopharmacol 16:849\u2013856","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05347-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-019-05347-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05347-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T00:00:43Z","timestamp":1597536043000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-019-05347-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,17]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["5347"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-05347-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,17]]},"assertion":[{"value":"18 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures were approved by the University of Maryland, Baltimore Animal Care and Use Committee and were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The contents of this manuscript do not represent the views of the U.S. Department of Veterans Affairs or the US Government.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"TDG has received research funding from Allergan, and Roche Pharmaceuticals, and consultant fees from FSV7 LLC during the preceding 3\u00a0years. LC reported having received support for Invited Lectures outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}